Compare
5 stocks, side by sideRelative performance · rebased to 100
IMVTPTGXPCVXSYREIBRX
| IMVTImmunovant, Inc. | PTGXProtagonist Therapeutics, Inc. | PCVXVaxcyte, Inc. | SYRESpyre Therapeutics, Inc. | IBRXImmunityBio, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 9/10 | 10/10 | 3/10 | 10/10 | 8/10 |
| Price | $38.24 | $122.63 | $53.68 | $88.67 | $7.79 |
| 1 month | +13% | +23% | +7.1% | +20% | -1.6% |
| 1 year | +139% | +128% | +57% | +475% | +179% |
| 5 year | +243% | +184% | +150% | -46% | -44% |
| P/E (TTM) | -15.5 | -68.8 | -8.2 | -42.9 | -9.5 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $7.9B | $7.9B | $7.8B | $7.7B | $8.2B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.